The Company

Adenovir Pharma AB was founded in 2008 by the innovators, P.U.L.S. AB and its partners and investors.

PULS is a life science company with a unique combination of scientists and industrialists who together with innovators are commercializing ideas by providing capital, know-how and committed partnership, www.pulsinvest.se

PULS has five active portfolio companies: Adenovir Pharma (eye infection), Belina Pharma (breast cancer), Glactone Pharma (immuno-oncology), Oncorena (renal cancer) and Trophea (skin atrophy). 

 

 


 

 

Glactone - Logotype

More information at the Glactone website


Oncorena - Logotype

More information on the Oncorena website


Corporate information 

Company name:Adenovir Pharma AB
Corporate identity number:556745-9986
Founded/Board:Helsingborg, Sweden, in 2008